Tregocel

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ixtrih issa

Ingredjent attiv:

Apium graveolens, Quantity: 50 mg (Equivalent: Apium graveolens, Qty 500 mg); Curcuma longa, Quantity: 100 mg; Zingiber officinale, Quantity: 15 mg (Equivalent: Zingiber officinale, Qty 165 mg); Harpagophytum procumbens, Quantity: 131.58 mg; Boswellia serrata, Quantity: 125 mg (Equivalent: Boswellia serrata, Qty 500 mg; Equivalent: boswellic acid, Qty 81.25 mg)

Disponibbli minn:

Pharmametics Products A Division of Max Biocare Pty Ltd

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; croscarmellose sodium; hypromellose; crospovidone; macrogol 400; calcium hydrogen phosphate; Carnauba Wax; magnesium stearate; povidone; titanium dioxide; purified talc; macrogol 4000; polyvinyl alcohol; quinoline yellow aluminium lake; carmoisine aluminium lake; lecithin; indigo carmine aluminium lake; lactose monohydrate; silicon dioxide; macrogol 3350

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Anti-inflammatory/relieve inflammation ; Analgesic/Anodyne/relieve pain ; Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; Maintain/support joint health ; Maintain/support joint mobility/flexibility ; Decrease/reduce/relieve mild joint pain/soreness ; Decrease/reduce/relieve mild joint stiffness ; Maintain/support healthy cardiovascular system function ; Maintain/support digestive system health ; Maintain/support liver health ; Maintain/support immune system health

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Listed

Data ta 'l-awtorizzazzjoni:

2019-06-12

Ara l-istorja tad-dokumenti